Cargando…
Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF
OBJECTIVE: To evaluate the efficacy of Abelmoschus manihot in treating type 2 diabetic nonproliferative retinopathy. METHODS: It was a randomized controlled clinical trial. The recruited eighty subjects with type 2 diabetic nonproliferative retinopathy were randomly divided into treatment group and...
Autores principales: | Zhao, Yue, Yu, Xu, Lou, Yan, Sun, Xinyi, Zhu, Boyu, Xu, Weilong, Zhou, Lei, Wu, Hao, Jin, Qingzi, Wang, Heng, Shen, Jianjiang, Yu, Jiangyi, An, Xiaofei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210540/ https://www.ncbi.nlm.nih.gov/pubmed/32419808 http://dx.doi.org/10.1155/2020/5204917 |
Ejemplares similares
-
Total flavones of Abelmoschus manihot improve diabetic nephropathy by inhibiting the iRhom2/TACE signalling pathway activity in rats
por: Liu, Su, et al.
Publicado: (2017) -
Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
por: Bahr, Tyler A., et al.
Publicado: (2023) -
The pharmacological mechanism of Abelmoschus manihot in the treatment of chronic kidney disease
por: Wei, Cuiting, et al.
Publicado: (2023) -
Total flavone of Abelmoschus Manihot improves colitis by promoting the growth of Akkermansia in mice
por: Bu, Fan, et al.
Publicado: (2021) -
Abelmoschus manihot for Diabetic Nephropathy: A Systematic Review and Meta-Analysis
por: Shi, Liwei, et al.
Publicado: (2019)